© 2005 Oxford University Press
ARTICLE |
Effects of Light and Food Schedules on Liver and Tumor Molecular Clocks in Mice
Affiliations of authors: INSERM E 0354 «Chronothérapeutique des cancers», Hôpital P. Brousse and Université Paris XI, 94807 Villejuif Cedex, France (EF, PFI, M-WW, X-ML, FL); Department of Oncology and Neurosciences, Università "G. D'Annunzio", 66013 Chieti, Italy (PFI, SI); Cancer Center, Sun Yat-sen University, Guangzhou, China (MWW, L-JX)
Correspondence to: Francis Lévi, MD, PhD, INSERM E 0354 "Cancer chronotherapeutics" (Université Paris XI), Paul Brousse Hospital, 94800 Villejuif, France (e-mail: levi-f{at}vjf.inserm.fr).
Background: Disrupted circadian coordination accelerates malignant growth, but the molecular mechanism is unclear. Methods: Healthy or Glasgow osteosarcoma–bearing mice (n = 162) were synchronized with light and darkness over 2–3 weeks, submitted to an 8-hour advance onset of light every 2 days (chronic jet lag) to disrupt circadian coordination, or submitted to chronic jet lag and meal timing to prevent molecular clock alteration. The expression of molecular clock genes and of the cell cycle genes c-Myc and p53 in liver and tumor was determined with quantitative reverse transcription–polymerase chain reaction at six circadian times over a 24-hour period of light and darkness and analyzed with analysis of variance and cosinor. Tumor weight was measured daily over the course of the experiment. All statistical tests were two-sided. Results: In synchronized mice, mean mRNA levels of clock genes Rev-erb
, Per2, and Bmal1 varied by 206-, four-, and 26-fold, respectively, over the 24 hours in healthy mouse liver; by 36-, 35-, and 32-fold in the livers of tumor-bearing mice; and by 9.4-, 5.5-, and sixfold in tumor tissue (P = .046 to <.001). In mice subjected to chronic jet lag, the periodic changes were dampened and the clock gene rhythms were temporally shifted in liver and ablated in tumor, and tumor growth was accelerated. Meal timing reversed the chronic jet lag–induced alterations in Rev-erb and Per2 expression in liver and of all three clock genes in tumor and slowed tumor growth. Tumor growth differed as a function of light and feeding schedules (P = .04). No obvious rhythm was detected for p53 or c-Myc in liver or tumor tissues of synchronized mice. In healthy mice subjected to chronic jet lag, the mean level of p53 expression was cut in half (P = .002), and a 12-fold circadian variation in c-Myc mRNA level (P = .03) was induced in the liver of healthy mice, whereas complex expression patterns were found in the liver and tumor of tumor-bearing mice. Conclusions: Altered light–dark or feeding schedules modified the expression of molecular clock genes and genes involved in carcinogenesis and tumor progression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Filipski and F. Levi Circadian Disruption in Experimental Cancer Processes Integr Cancer Ther, December 1, 2009; 8(4): 298 - 302. [Abstract] [PDF]
|
|
|
|
|
|
V. T. Vasu, C. E. Cross, and K. Gohil Nr1d1, an Important Circadian Pathway Regulatory Gene, Is Suppressed By Cigarette Smoke in Murine Lungs Integr Cancer Ther, December 1, 2009; 8(4): 321 - 328. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Levi, A. Altinok, J. Clairambault, and A. Goldbeter Implications of circadian clocks for the rhythmic delivery of cancer therapeutics Phil Trans R Soc A, October 13, 2008; 366(1880): 3575 - 3598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Levi, E. Filipski, I. Iurisci, X. M. Li, and P. Innominato Cross-talks between Circadian Timing System and Cell Division Cycle Determine Cancer Biology and Therapeutics Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 465 - 475. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Iurisci, E. Filipski, J. Reinhardt, S. Bach, A. Gianella-Borradori, S. Iacobelli, L. Meijer, and F. Levi Improved Tumor Control through Circadian Clock Induction by Seliciclib, a Cyclin-Dependent Kinase Inhibitor. Cancer Res., November 15, 2006; 66(22): 10720 - 10728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gholam, S. Giacchetti, C. Brezault-Bonnet, M. Bouchahda, D. Hauteville, R. Adam, B. Ducot, O. Ghemard, F. Kustlinger, C. Jasmin, et al. Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer Oncologist, November 1, 2006; 11(10): 1072 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Giacchetti, G. Bjarnason, C. Garufi, D. Genet, S. Iacobelli, M. Tampellini, R. Smaaland, C. Focan, B. Coudert, Y. Humblet, et al. Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group J. Clin. Oncol., August 1, 2006; 24(22): 3562 - 3569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Davidson Search for the feeding-entrainable circadian oscillator: a complex proposition Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1524 - R1526. [Full Text] [PDF]
|
|
|
|
 |
|
 X.-M. Li, S. Kanekal, D. Crepin, C. Guettier, J. Carriere, G. Elliott, and F. Levi Circadian pharmacology of L-alanosine (SDX-102) in mice. Mol. Cancer Ther., February 1, 2006; 5(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|